MedTrace Logo

Assessing the Effectiveness and Safety of Pericapsular Nerve Group (PENG) Block in Hip Fracture Patients on Antithrombotic Therapy

NCT06582667 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-09-03

No results posted yet for this study

Summary

PENG block will be done on patients with hip fracture either receiving antithrombotic therapy or not under ultrasound guidance

Conditions

  • Hip Fracture
  • Antithrombotic Therapy
  • PENG Block

Interventions

PROCEDURE

PENG block

US guided PENG block in hip fracture without anti thrombotic therapy

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-17
Primary Completion
2025-01-17
Completion
2025-04-17

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06582667 on ClinicalTrials.gov